SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Instagram Outage Disrupts Thousands of U.S. Users 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock 
BOSTON, Dec. 13, 2016 -- Novaseek Research LLC, a health information technology for life sciences company, today announced that Kate Torchilin, PhD, MBA, Chief Executive Officer, will present at the upcoming Digital Medicine Showcase 2017, which takes place concurrently with the JP Morgan 35th Annual Healthcare Conference in San Francisco. Dr. Torchilin’s presentation will take place at 2:15 PM Pacific on Tuesday, January 10, at the Parc 55 San Francisco – Union Square.
In her presentation, Dr. Torchilin will provide an overview of Novaseek’s Clinical Data Network for Research (CDNR) platform and discuss how CDNR enables researchers turnkey access to clinical data and data-enriched, consented human biospecimens for use in real-world data and translational medicine studies in the areas of oncology, immune-oncology, cardiovascular disease, diabetes, neuroscience and more. She also will share how CDNR helps researchers define patient cohorts through population analytics and supports historical and longitudinal tracking and the collection of biospecimens and associated clinical data to stratify patients for studies.
About Novaseek
Novaseek Research LLC is a game-changing health IT for life sciences company that transforms how biomedical researchers access clinical data and human biospecimens for real-world data and precision medicine studies. Novaseek powers speedy and successful discovery, translational medicine, and real-world data studies by providing easy access to patients, longitudinal patient data and biospecimens via its award-winning Clinical Data Network for Research (CDNR) SaaS platform. We envision a world where a clear understanding of real-world patients is central to every stage of life sciences research and drug development. For more information, please visit www.novaseekresearch.com.
Media Contact: Terri Clevenger Continuum Health Communications [email protected] (203) 856-4326
